Skip to main content
Cachet Pharmaceutical Co., Ltd. logo

Cachet Pharmaceutical Co., Ltd. — Investor Relations & Filings

Ticker · 002462 ISIN · CNE100000SN0 LEI · 300300CBONJS7HUOCX64 Shenzhen Stock Exchange Wholesale and retail trade
Open in API
Filings indexed 1,441 across all filing types
Latest filing 2016-06-13 Regulatory Filings
Country CN China
Listing Shenzhen Stock Exchange 002462

About Cachet Pharmaceutical Co., Ltd.

https://www.cachet.com.cn

Cachet Pharmaceutical Co., Ltd. specializes in the distribution and retail of pharmaceutical products and medical devices. The company operates an extensive wholesale network and a chain of retail pharmacies, providing comprehensive supply chain solutions to healthcare institutions and end-consumers. Its core operations include the procurement, storage, and logistics of western medicines, traditional Chinese medicines, and high-value medical consumables. Cachet Pharmaceutical emphasizes modern logistics management and professional pharmaceutical services, leveraging a robust distribution infrastructure to ensure the efficient delivery of healthcare products. The company also focuses on hospital supply chain integration and community-based retail services to enhance healthcare accessibility.

Recent filings

Filing Released Lang Actions
关于签订日常经营合同的公告
Regulatory Filings Classification · 95% confidence The document is a public announcement by a company about signing a routine business contract related to pharmaceutical supply cooperation. It details the contract parties, terms, pricing, impact on the company, risk factors, and approval procedures. There is no financial statement, no quarterly or annual report data, no audit information, no management discussion of financial results, no earnings highlights, no voting results, no legal proceedings, no merger or acquisition activity, and no executive compensation details. The document is a formal announcement of a contract signing, which is a regulatory disclosure about a material contract. It does not fit into financial report categories like Annual Report (10-K), Interim Report (IR), or Earnings Release (ER). It is not a report publication announcement since it contains substantive contract details rather than just a notice of report availability. The best fitting category is Regulatory Filings (RNS), which is the fallback for miscellaneous regulatory announcements that do not fit other categories.
2016-06-13 Chinese
2015年度股东大会的法律意见书
AGM Information Classification · 95% confidence The document is a legal opinion letter from a law firm regarding the 2015 Annual General Meeting (AGM) of 嘉事堂药业股份有限公司. It details the legality and compliance of the AGM procedures, attendance, voting results, and resolutions passed. The document includes voting results on various agenda items such as the 2015 annual report, profit distribution plan, and other corporate matters. It does not contain the actual annual report or financial statements but rather confirms the validity of the AGM and its resolutions. This type of document is typically classified as AGM Information (AGM-R) because it relates to materials shared or produced in connection with the AGM, specifically a legal opinion on the AGM proceedings and outcomes.
2016-05-10 Chinese
2015年度股东大会会议决议暨中小投资者表决结果公告
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is a detailed announcement of the resolutions and voting results from the 2015 Annual General Meeting (AGM) of 嘉事堂药业股份有限公司. It includes information about the meeting date, attendance, voting results on various agenda items including the annual report, financial statements, profit distribution, and other corporate matters. The document also mentions the legal opinion from a law firm confirming the legality of the meeting and resolutions. The content is focused on the AGM meeting decisions and voting outcomes rather than the full annual report or financial statements themselves. The document length is 4614 characters, which is relatively short and consistent with an announcement rather than a full report. Therefore, this document fits the category of Declaration of Voting Results & Voting Rights Announcements (DVA).
2016-05-10 Chinese
第五届董事会第六次会议决议的公告
Board/Management Information Classification · 95% confidence The document is an announcement of the resolution passed at the company's board meeting regarding the approval of the full 2016 annual report. It references the annual report and quarterly reports but does not contain the actual report or detailed financial data itself. The document is short (667 characters) and serves as a formal notice of the board's decision to approve the annual report, consistent with a Board/Management Information announcement rather than the report itself. Therefore, it should be classified as MANG (Board/Management Information).
2016-04-20 Chinese
2016年第一季度报告全文
Interim / Quarterly Report Classification · 95% confidence The document is titled as 嘉事堂药业股份有限公司 2016 年第一季度报告全文, which translates to the full text of the 2016 first quarter report of the company. It contains detailed financial data for the first quarter of 2016, including revenue, net profit, cash flow, earnings per share, and changes in assets and liabilities. It also includes shareholder information and detailed notes on important matters affecting the company during the quarter. The length is about 15,000 characters, indicating a full report rather than a brief announcement. The content is consistent with an Interim / Quarterly Report, which provides comprehensive financial statements and analysis for a period shorter than a full fiscal year. Therefore, the document should be classified as an Interim / Quarterly Report (IR). Q1 2016
2016-04-20 Chinese
2016年第一季度报告正文
Interim / Quarterly Report Classification · 100% confidence The document is titled as 嘉事堂药业股份有限公司 2016 年第一季度报告正文, which translates to Jia Shi Tang Pharmaceutical Co., Ltd. 2016 First Quarter Report. It contains detailed financial data such as revenue, net profit, cash flow, earnings per share, and changes in shareholders. It also includes explanations of financial changes, important events, and shareholder information for the quarter. The presence of comprehensive financial statements and analysis for a period shorter than a full fiscal year (the first quarter of 2016) clearly indicates this is an Interim / Quarterly Report. The document length is substantial (15,000 characters), and it contains actual financial data, not just an announcement or certification. Therefore, the correct classification is Interim / Quarterly Report (IR). Q1 2016
2016-04-20 Chinese

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.